Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
about
Cirrhosis: new research provides a basis for rational and targeted treatmentsAlcohol abuse: critical pathophysiological processes and contribution to disease burdenAlcoholic hepatitis: a comprehensive review of pathogenesis and treatmentCritical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical TrialsProfiles of serum cytokines in acute drug-induced liver injury and their prognostic significanceTranscriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway.Toll-like receptors in the pathogenesis of alcoholic liver disease.Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver diseaseTreatment of alcoholic liver disease.Measurement of serum, liver, and brain cytokine induction, thiamine levels, and hepatopathology in rats exposed to a 4-day alcohol binge protocol.Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.Immunological response in alcoholic liver disease.Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related DifferencesReview article: current management of alcoholic liver disease.Targeted treatments for cirrhosis.Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells.Immune dysfunction in acute alcoholic hepatitis.Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease.Emerging therapies for liver fibrosis.How to modulate inflammatory cytokines in liver diseases.Current concepts and controversies in the treatment of alcoholic hepatitis.A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.Current and future anti-fibrotic therapies for chronic liver disease.The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes.Focus on: Alcohol and the liver.Infliximab and Dexamethasone Attenuate the Ductular Reaction in Mice.Signalling pathways in alcohol-induced liver inflammation.Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease.Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway.Alcoholic liver disease: pathogenesis and new targets for therapy.Alcohol, psoriasis, liver disease, and anti-psoriasis drugs.Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapiesThe effect of inflammatory cytokines in alcoholic liver disease.Prognosis and treatment of patients with acute alcoholic hepatitis.Alcoholic hepatitis: current management.Extracorporeal liver support in severe alcoholic hepatitis.Acute-on-chronic liver failure: terminology, mechanisms and management.Alcoholic Hepatitis: Risk Factors, Pathogenesis, and Approach to Treatment.
P2860
Q24527263-C91FEF8E-048B-4234-A343-7211ED90E469Q27010642-5C8A0B6B-7A5B-4AAC-B450-7C434C8F5D3FQ27027418-1CB670D8-27B0-410E-82F8-538449BA43F0Q28073542-9FB027CC-8C8A-46B4-ABBC-4CD1C31133FCQ28538041-8676A62F-EEC7-4B99-895B-990A0B34A4E0Q33783707-6384F100-660D-494F-BA26-5E06377F71A3Q33837498-4F02E394-1FD3-479D-A382-43533B9AAAC6Q34106192-4D3ADB69-AA7A-44DE-8061-A0DD14D39D15Q34489050-F02644FB-CBE8-4A7D-BC45-FCBA146B729CQ34565692-E0CAF0DC-37EF-45C5-8522-E7CE68E5B8BAQ35361640-227631C4-5F6D-4E77-8458-6E8989CF7C93Q35595929-AF21367F-6D08-4941-9E8E-828BB72BABE6Q35615727-183CAC7A-35C7-4FBF-B667-6D128B4E2B20Q35673289-212020D5-B41F-4D7B-AB01-3141E7918EBFQ35714125-B75DC7C6-13C5-4410-BF82-809C53248FB8Q35911123-A042ADC7-D0A0-4373-A244-584B68409964Q35980026-4E62641F-0A34-4A55-9D8A-2FE8872B1308Q36269642-8B1A31DB-0781-4354-9DA7-B450D6C568E4Q36315771-CC20E6EF-D768-4D4B-AB2E-879B5807FB66Q36478124-A2F8CA71-AFA9-43B5-90CF-FB2CCAA827F8Q36619707-33EC58E8-24E0-4DE7-BB8F-A890C2C882EBQ36655119-1B6CBEA8-13E8-4B97-B10E-97366B387BA4Q37091511-FCA9B4FA-7DBA-4E06-A437-83FF4726AF37Q37317654-E46E916F-DE6E-4D21-ACC1-A9F4810F162EQ37354457-F7F6844F-1EE5-463A-AF6C-DA2C8E0868DDQ37386702-C2454890-A289-49E8-BD90-FC8083ABE3E1Q37401029-5B6D3599-7E80-408D-8C2D-B4D3756C6C73Q37461766-31FA6064-0CDA-45A0-8A21-5AD3C00BA2CEQ37533461-0CDD0550-DA29-44CD-A463-6205156EA237Q37711307-C2CA6632-27F9-48A6-82E7-D7326CCF21D4Q37913987-29E6BB90-109E-49EA-8E45-19D2D0399C90Q37946497-16A83EE6-F3FF-42DB-A744-66B843257C79Q37959188-EE9040B5-E351-4BAE-B84F-85EC2E6FE048Q38073028-915FC11D-E9BD-49B8-987C-FE7CE86FFFBBQ38175384-AAF0B8DF-A43B-4BCD-B665-0743D645D2F9Q38203313-9CD90AAD-B939-4314-B1D2-17A8428CA5FCQ38209601-CD1C3BE5-9BFD-4462-BF73-7D135CC9852DQ38227837-FB85B61F-92FE-45D7-9C36-F1CD19133D31Q38720387-09645A42-EEE4-47BC-A7AD-A425691C510CQ38721974-3F933A13-E69A-4EA2-94A9-77E43EDA307E
P2860
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@en
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@nl
type
label
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@en
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@nl
prefLabel
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@en
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis.
@nl
P2093
P1476
Anti-tumor necrosis factor-alp ...... in severe alcoholic hepatitis
@en
P2093
Akeel Alisa
Arthur Kaser
Christian Datz
Detlef Schuppan
Felix A Offner
Heinz Zoller
Herbert Tilg
Ivo Graziadei
Michael Trauner
Nathan A Davies
P304
P356
10.1016/S0168-8278(02)00442-7
P577
2003-04-01T00:00:00Z